Genmab AS (GMAB)
20.65
+0.18
(+0.88%)
USD |
NASDAQ |
Nov 22, 16:00
20.92
+0.27
(+1.31%)
After-Hours: 20:00
Genmab Price to Book Value: 2.743 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.719 |
| November 20, 2024 | 2.716 |
| November 19, 2024 | 2.723 |
| November 18, 2024 | 2.746 |
| November 15, 2024 | 2.735 |
| November 14, 2024 | 2.814 |
| November 13, 2024 | 2.877 |
| November 12, 2024 | 2.985 |
| November 11, 2024 | 3.082 |
| November 08, 2024 | 3.066 |
| November 07, 2024 | 3.070 |
| November 06, 2024 | 2.966 |
| November 05, 2024 | 3.022 |
| November 04, 2024 | 3.026 |
| November 01, 2024 | 2.997 |
| October 31, 2024 | 2.965 |
| October 30, 2024 | 2.998 |
| October 29, 2024 | 3.071 |
| October 28, 2024 | 3.074 |
| October 25, 2024 | 3.071 |
| October 24, 2024 | 3.031 |
| October 23, 2024 | 3.019 |
| October 22, 2024 | 3.025 |
| October 21, 2024 | 3.026 |
| October 18, 2024 | 3.053 |
| Date | Value |
|---|---|
| October 17, 2024 | 3.050 |
| October 16, 2024 | 3.002 |
| October 15, 2024 | 3.079 |
| October 14, 2024 | 3.143 |
| October 11, 2024 | 3.126 |
| October 10, 2024 | 3.150 |
| October 09, 2024 | 3.142 |
| October 08, 2024 | 3.134 |
| October 07, 2024 | 3.112 |
| October 04, 2024 | 3.120 |
| October 03, 2024 | 3.108 |
| October 02, 2024 | 3.147 |
| October 01, 2024 | 3.208 |
| September 30, 2024 | 3.239 |
| September 27, 2024 | 3.476 |
| September 26, 2024 | 3.446 |
| September 25, 2024 | 3.404 |
| September 24, 2024 | 3.430 |
| September 23, 2024 | 3.448 |
| September 20, 2024 | 3.647 |
| September 19, 2024 | 3.783 |
| September 18, 2024 | 3.743 |
| September 17, 2024 | 3.776 |
| September 16, 2024 | 3.797 |
| September 13, 2024 | 3.843 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.716
Minimum
Nov 20 2024
10.20
Maximum
Jun 25 2020
6.649
Average
6.766
Median
Price to Book Value Benchmarks
| Novo Nordisk AS | 25.87 |
| Ascendis Pharma AS | -- |
| Galecto Inc | 0.3642 |
| Evaxion Biotech AS | 112.57 |
| IO Biotech Inc | 0.6533 |
Price to Book Value Related Metrics
| PE Ratio | 19.62 |
| PS Ratio | 4.659 |
| PEG Ratio | 1.313 |
| Price to Free Cash Flow | 14.03 |
| Price | 20.65 |
| Earnings Yield | 5.10% |
| Market Cap | 13.12B |
| PEGY Ratio | 1.313 |
| Operating PE Ratio | 14.25 |
| Normalized PE Ratio | 17.36 |